Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John T Durkin

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|September 9, 2004
The case against stem cell researchJohn T Durkin
Brain Research|December 9, 2010
Amino-terminal isoforms of the human glycine transporter GlyT1 exhibit similar pharmacologyJohn T Durkin, Chrysanthe M Spais, Justin Schreiber, et al.
Biochemical Pharmacology|July 20, 2010
Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 miceKarla Kopec, Dorothy G Flood, Maciej Gasior, et al.
Biochemistry|March 3, 2009
ALK mutants in the kinase domain exhibit altered kinase activity and differential sensitivity to small molecule ALK inhibitorsLihui Lu, Arup K Ghose, Matthew R Quail, et al.
Biochemistry|December 22, 2004
Phosphoregulation of mixed-lineage kinase 1 activity by multiple phosphorylation in the activation loopJohn T Durkin, Beverly P Holskin, Karla K Kopec, et al.
Journal of Medicinal Chemistry|August 22, 2008
Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: optimization, mixed-lineage kinase 1 crystallography, and oral in vivo activity in 1-methyl-4-phenyltetrahydropyridine modelsRobert L Hudkins, James L Diebold, Ming Tao, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|September 9, 2004
The case against stem cell researchJohn T Durkin
Brain Research|December 9, 2010
Amino-terminal isoforms of the human glycine transporter GlyT1 exhibit similar pharmacologyJohn T Durkin, Chrysanthe M Spais, Justin Schreiber, et al.
Biochemical Pharmacology|July 20, 2010
Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 miceKarla Kopec, Dorothy G Flood, Maciej Gasior, et al.
Biochemistry|March 3, 2009
ALK mutants in the kinase domain exhibit altered kinase activity and differential sensitivity to small molecule ALK inhibitorsLihui Lu, Arup K Ghose, Matthew R Quail, et al.
Biochemistry|December 22, 2004
Phosphoregulation of mixed-lineage kinase 1 activity by multiple phosphorylation in the activation loopJohn T Durkin, Beverly P Holskin, Karla K Kopec, et al.
Journal of Medicinal Chemistry|August 22, 2008
Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: optimization, mixed-lineage kinase 1 crystallography, and oral in vivo activity in 1-methyl-4-phenyltetrahydropyridine modelsRobert L Hudkins, James L Diebold, Ming Tao, et al.
Pageof 1